Integrating Transcriptomics, Genomics, and Proteomics to Drive Scientific Discovery in Kenya
Pioneering biotechnology and molecular research across East Africa's leading commercial and academic hubs.
Kenya is rapidly positioning itself as the scientific research hub of East Africa. Driven by world-class institutions in Nairobi, such as the Kenya Medical Research Institute (KEMRI), the International Livestock Research Institute (ILRI), and leading academic entities like the University of Nairobi (UoN) and Jomo Kenyatta University of Agriculture and Technology (JKUAT), the demand for high-end molecular technologies has reached an all-time high.
Quantitative Proteomics—the systematic analysis of protein expression, post-translational modifications, and protein-protein interactions—has transitioned from a niche research tool to an essential driver of local bio-industrial and clinical innovations. By quantifying the dynamic proteome, Kenyan researchers are unlocking complex biological pathways that genomics alone cannot fully explain.
Biomarker Technologies (BMKGene) supports this scientific evolution by providing accessible, state-of-the-art sequencing and quantitative proteomics workflows. With our advanced platforms and transparent pricelists, we help local laboratories bypass logistical bottlenecks, providing direct access to global-standard multi-omics pipelines.
Proteomic profiling of local staples like maize, sorghum, and cassava to identify stress-response proteins, aiding the breeding of drought- and pest-resistant crops.
Mapping host-pathogen interactions in malaria, tuberculosis, and Rift Valley fever to discover novel diagnostic biomarkers and therapeutic targets.
Analyzing the milk and serum proteome of local cattle breeds to enhance resistance against endemic diseases such as East Coast Fever.
How multi-omics and quantitative proteomics address real-world challenges in East African agriculture, health, and conservation.
Kenyan agricultural research institutes leverage comparative proteomics and genomics to analyze plant defense mechanisms. Understanding differential protein expression under drought conditions allows scientists to accelerate marker-assisted selection for food security programs.
Local clinical research centers utilize quantitative proteomics to profile patient cohorts, paving the way for personalized medicine in oncology and infectious disease management. Identifying protein biomarkers in serum or tissue helps track disease progression and therapeutic efficacy.
Protecting Kenya's rich biodiversity requires deep physiological insights. Proteomics enables non-invasive health monitoring of endangered wildlife species and the development of targeted veterinary vaccines for livestock, protecting pastoralist livelihoods.
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Our state-of-the-art facilities house a comprehensive array of advanced instrumentation, enabling seamless integration of transcriptomic, genomic, and proteomic workflows:
Our facilities boast advanced biomolecular laboratory instruments, standard labs for sample extraction, library construction, clean rooms, and sequencing labs. Every project follows standard procedures from sample extraction to sequencing under strict Standard Operating Procedures (SOPs).
The self-developed BMKCloud platform features CPUs with 41,104 memory, 3 PB total storage, and 4,260 computing cores, achieving a peak computing power of over 121,708.8 Gflop per second. This powerful computing infrastructure ensures that researchers in Kenya and worldwide can analyze massive multi-omics datasets quickly, securely, and efficiently.
Improving throughput, quality, and delivery speed for Kenyan and global scientific projects.
Biomarker Technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to high-throughput NGS library construction services.
BMKGENE strives to greatly improve our entire line of sequencing and omics products in terms of variety, throughput, delivery quality, and cycle time. This automated pipeline minimizes human error, standardizes preparation quality, and ensures highly reproducible datasets for demanding quantitative proteomics and genomics studies.









Watch our Brilliant Lab 1000 (BL1000) automated platform in action.
Understanding the factors influencing proteomics costs and how to optimize your research budget.
Navigating the costs of quantitative proteomics services can be complex for researchers in Kenya due to shipping logistics, import duties, and sample preparation variations. At BMKGene, we maintain a transparent, highly competitive pricing structure tailored to support institutional research budgets in East Africa. The final cost of a quantitative proteomics project is generally influenced by several key parameters:
The choice of quantification method significantly impacts the pricing. Tandem Mass Tagging (TMT) allows multiplexing of up to 16 or 18 samples, reducing instrument run time but requiring chemical labeling kits, which are factored into the reagent cost. Label-free quantification (LFQ) and Data-Independent Acquisition (DIA) require no labeling reagents, making them more cost-effective for large sample cohorts, though they demand highly stable chromatographic runs.
Complex samples (e.g., blood plasma, plant tissues with high starch/polyphenols, or wildlife tissue) require specialized extraction protocols and depletion of high-abundance proteins to detect low-abundance biomarkers. Professional sample prep services, including protein extraction, clean-up, and digestion, are available to ensure the highest data quality before MS injection.
Deeper proteome coverage requires off-line peptide fractionation prior to LC-MS/MS analysis. While fractionation increases the number of identified proteins (often exceeding 8,000 proteins in mammalian cells), it multiplies the instrument time required, adjusting the cost per sample accordingly.
Standard data analysis (protein identification, quantification, and basic statistical tests) is typically bundled with our services. Advanced bioinformatics, including pathway enrichment (KEGG/GO), network analysis, and integrated multi-omics modeling on the BMKCloud platform, can be added to provide publication-ready figures directly to researchers in Nairobi, Eldoret, or Mombasa.
Are you planning a genomics or proteomics project in Kenya? Contact our local support team to receive a detailed breakdown of costs, sample shipping guidelines, and special academic discounts.
Enterprise QualificationOur commitment to international quality standards, rigorous quality control, and scientific excellence.
Integrating transcriptome sequencing, whole-genome sequencing, epigenetics, and comparative genomics
We will be in touch within 24 hours to assist with your project details and pricing options.
Inquiry Now